Toxicity study in naïve mice
Buyer: BiconY Therapeutics GmbH
- Published
- 16 December 2025
- Procedure
- Open procedure
- Lots
- 1
- Notice number
- 00835029-2025
- Reference
- 06e49d9a-34f3-43b1-bba8-231891425772
- Official source
- Official source
CPV codes
- 73000000Servicios de investigación y desarrollo y servicios de consultoría conexos
Description
The Federal Agency for Disruptive Innovation - SPRIND GmbH ("SPRIND") - aims to cre-ate new disruptive innovations from Germany. That means products, services and sys-tems that make all our lives noticeably and sustainably better. To achieve this, SPRIND brings together new thinkers from science and business, people with outstanding ideas, special expertise, and passion. Hence, SPRIND provides an entrepreneurial environment that turns ideas into reality. The objective of BiconY Therapeutics GmbH, a SPRIND subsidiary, is the development of a bispecific antibody combination for the treatment of solid tumours. The combination con-sists of proprietary, bispecific CD3 anti-bodies (bsAbCD3) and bispecific CD28 co-stimulators (BiCos), which, when used together, significantly im-prove the specificity, sus-tainability, and efficiency of a T cell recruitment and thus the immune response against tumour cells. The aim of the research and development activities is to provide proof of concept for the effect of bispecific antibody therapy in the form of two phase I/IIa clinical trials. For the IND application at Paul Ehrlich Institute (Germany) we have to show safety of our molecules in animal …
Award criteria
- Price — The award criterion price will be evaluated as follows: The lowest bid price according to the Price sheet (Form for offer) will be awarded the highest number of points (5). The number of points for…
- Quality — The award criterion Date of final QA Report (audited) will be evaluated as follows: Date Points Till March 27, 2026 5 Till April 3, 2026 4 Till April 11, 2026 …
Awards
| Awarded to | Amount | Date |
|---|---|---|
| vivo Science GmbH | €-1 | — |
Official publications
- TED · 00835029-2025 · 16 December 2025
- OJS · 242/2025 · 16 December 2025
Other tenders from BiconY Therapeutics GmbH
Frequently asked questions
- Who is the buyer of this tender?
- The contracting authority is BiconY Therapeutics GmbH (European Union).
- How can I bid for public tenders in European Union?
- Bids are submitted through the official procurement portal of European Union. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Create a free account and receive new tenders from European Union matching your business, every day.